Home » Press Release » Archive by category "2014"

December 2, 2014

Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,900,579 entitled “Siglec-15 antibodies in treating bone loss-related diseases” by the United States Patent and Trademark Office (“USPTO”)

August 12, 2014

Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,802,826  entitled “Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume” by the United States Patent and Trademark Office (“USPTO”)

August 1, 2014

Alethia Biotherapeutics announces the issuance of patent JP5589149  entitled “Polynucleotides and polypeptide sequences involved in cancer ” by the Japan Patent Office

June 20, 2014

Alethia Biotherapeutics announces the issuance of patent JP5564249 entitled “Polynucleotides and polypeptide sequences involved in cancer ” by the Japan Patent Office

June 3, 2014

Alethia Biotherapeutics announces the issuance of U.S. Patent No. 8,741,289  entitled “Siglec-15 antibodies in treating bone loss-related diseases” by the United States Patent and Trademark Office (“USPTO”)

March 5, 2014

Alethia Biotherapeutics announces the issuance of patent EP2275547 entitled “Polynucleotides and polypeptide sequences involved in the process of bone remodeling ” by the European Patent Office

January 20, 2014

Alethia Biotherapeutics announces publication of data about its bone antiresorptive program published in the Journal of Biological Chemistry: “Mechanism and function of monoclonal antibodies targeting siglec-15 for therapeutic inhibition of osteoclastic bone resorption”.

http://www.jbc.org/content/289/10/6498.long